Avidity Biosciences (RNA) Research & Development (2019 - 2025)
Historic Research & Development for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to $154.9 million.
- Avidity Biosciences' Research & Development rose 10071.76% to $154.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.2 million, marking a year-over-year increase of 8719.87%. This contributed to the annual value of $303.6 million for FY2024, which is 5897.58% up from last year.
- According to the latest figures from Q3 2025, Avidity Biosciences' Research & Development is $154.9 million, which was up 10071.76% from $138.1 million recorded in Q2 2025.
- Avidity Biosciences' 5-year Research & Development high stood at $154.9 million for Q3 2025, and its period low was $20.7 million during Q1 2021.
- In the last 5 years, Avidity Biosciences' Research & Development had a median value of $47.7 million in 2023 and averaged $59.9 million.
- In the last 5 years, Avidity Biosciences' Research & Development surged by 27296.18% in 2021 and then soared by 724.57% in 2023.
- Avidity Biosciences' Research & Development (Quarter) stood at $33.0 million in 2021, then surged by 38.35% to $45.6 million in 2022, then rose by 15.8% to $52.8 million in 2023, then surged by 81.05% to $95.6 million in 2024, then surged by 62.04% to $154.9 million in 2025.
- Its Research & Development stands at $154.9 million for Q3 2025, versus $138.1 million for Q2 2025 and $99.5 million for Q1 2025.